The evolving landscape of pharmacotherapy for spinal cord injury: Three decades of progress and future prospects
Spine Research · 2026-06 · 2 (2) · 121-131
DOI: 10.1097/br9.0000000000000033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spine Research, online erschienen am 19.06.2026. Verfasst von Duan Sun und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pharmacological interventions for spinal cord injury have shifted from symptom management to complex regenerative strategies over the past three decades. This study aimed to systematically synthesize this trajectory and identify emerging research paradigms.
Methods
A bibliometric analysis was conducted using the Web of Science Core Collection. A total of 3,470 original research articles published between 1992 and 2025 were retrieved. Network analysis (via CiteSpace) was performed to decode publication trends, collaborative patterns, and the evolution of research foci.
Results
Research foci transitioned from generalized antiinflammatory strategies toward targeted molecular pathways and regenerative mechanisms. The United States maintained historical leadership in citation impact, while China demonstrated explosive growth in research output since 2022. Key research hotspots evolved from traditional small-molecule drugs to advanced frontiers, including nanomedicine, biomaterial scaffolds, exosomes, hydrogels, and cell-free therapies.
Conclusions
Pharmacotherapy for spinal cord injury is transitioning toward precision medicine. Combinatorial strategies integrating advanced drug delivery systems with targeted drugs represent a promising trajectory toward functional neural repair.
Zitieren
APA
Sun, D., Liang, W., Xu, Y., Zhang, X., Yang, Y., Yin, P., Qu, X., Han, B., & Hai, Y. (2026). The evolving landscape of pharmacotherapy for spinal cord injury: Three decades of progress and future prospects. Spine Research, 2(2), 121-131. https://doi.org/10.1097/br9.0000000000000033
Vancouver
Sun D, Liang W, Xu Y, Zhang X, Yang Y, Yin P, et al. The evolving landscape of pharmacotherapy for spinal cord injury: Three decades of progress and future prospects. Spine Research. 2026;2(2):121-131. doi:10.1097/br9.0000000000000033
BibTeX
@article{Sun2026,
author = {Sun, Duan and Liang, Weishi and Xu, Yeqiu and Zhang, Xinan and Yang, Yihan and Yin, Peng and Qu, Xianjun and Han, Bo and Hai, Yong},
title = {The evolving landscape of pharmacotherapy for spinal cord injury: Three decades of progress and future prospects},
journal = {Spine Research},
year = {2026},
volume = {2},
number = {2},
pages = {121--131},
doi = {10.1097/br9.0000000000000033}
}
EUVIMED